0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Other Articles |

HISTAMINASE IN THE TREATMENT OF ALLERGIC DERMATOSES

LAWRENCE C. GOLDBERG, M.D.
JAMA. 1940;115(6):429-432. doi:10.1001/jama.1940.02810320009004.
Text Size: A A A
Published online

The discovery by Best and McHenry1 of an enzyme which specifically inactivates histamine suggests its use in the treatment of allergic cutaneous disorders. It has been shown that there is a release of so-called H substance in the blood during allergic shock and that this H substance may be histamine. Innumerable writers have endeavored to demonstrate the fact that histamine must be the trigger mechanism which prepares the skin for various reactions, particularly the so-called triple response of vasodilatation (streak), wheal exudative (edema) and reflex nervous dilatation (flare), which is dermatographism or urticaria itself.2 If this fact is true, then the assumption that treatment of these allergic states with histaminase is well founded and worthy of an extended trial before being discarded as another false hope in the long list of attempts to combat the allergic dermatoses.

Histamine may be obtained from the liver, lungs, skin and other

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();